Mylan's stance on certain generic drugs has changed significantly over the past decade, with the company put in a similar position now to one its CEO lambasted 10 years ago. Mylan CEO Heather ...

Mylan’s CEO, Heather Bresch, has been forced to defend the pricing of its EpiPen under sceptical questioning from US politicians. Bresch (pictured) was summoned to a hearing in front of the ...

GSK can breathe easy as new CEO Emma Walmsley takes over, following the FDA rejection of Mylan’s generic version of big-selling respiratory drug Advair. The US patent on Advair (fluticasone ...

To make things more complicated, Mylan's CEO Heather Bresch is the daughter of Senator Joe Manchin of West Virginia. Bloomberg caught up with the senator Tuesday to discuss his daughter and the ...

Lifecore now operates at less than 35% utilization, meaning that it can almost triple revenue with virtually no additional ...

Well, that was fast. It took Gov. Jim Justice all of one day after winning a seat in the U.S. Senate to play an exclusive game of political nepotism, appointing his wife, Cathy, to a nine-year term on ...

Zero. Congress’s sole contribution to the existence of a handy device that keeps your children from dying from bee stings is the fact that Mylan CEO Heather Bresch is the daughter of a ...

Mylan CEO Heather Bresch has drawn public scrutiny for raising the US list price on a pack of two injectors nearly six-fold to $600 since 2008. Affordability has become a bigger issue with the ...

Mylan President Rajiv Malik and Emcure Pharmaceuticals CEO Satish Mehta are both named as defendants to the 243-page complaint, which was transferred from Connecticut to Philadelphia. Led by ...

After Viatris’ CEO earlier this year promised to be “opportunistic ... Amid GLP-1 craze, Novo and Mylan ink patent settlement in Ozempic case After a long and tortuous path to approval ...

ALK’s CEO Peter Halling said: “While we believe that nasal delivery ... Therefore, we will maintain a portfolio approach to ...